Apolipoprotein A1 (apoA1), the major protein constituent of high-density lipoproteins (HDL), has been previously considered as a potential treatment target for restenosis7–10 and as a modulator of atherosclerosis progression11. The gene discussed is APOA1; the disease is atherosclerosis.